Nextbiomedical Co (XKRX:389650) Enterprise Value : ₩299,682 Mil (As of May. 16, 2025)

Nextbiomedical Co Enterprise Value Chart

Nextbiomedical Co Quarterly Data
	Dec20	Dec21	Dec22	Mar23	Sep23	Dec23	Mar24	Sep24	Dec24
Enterprise Value	Get a 7-Day Free Trial				-	-	-	303,373.30	300,907.96

Competitive Comparison of Nextbiomedical Co's Enterprise Value

For the Biotechnology subindustry, Nextbiomedical Co's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nextbiomedical Co's Enterprise Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nextbiomedical Co's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Nextbiomedical Co's Enterprise Value falls into.

Nextbiomedical Co Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Nextbiomedical Co's Enterprise Value for the fiscal year that ended in Dec. 2024 is calculated as

Nextbiomedical Co's Enterprise Value for the quarter that ended in Dec. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nextbiomedical Co  (XKRX:389650) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Nextbiomedical Co's EV-to-EBIT for today is

Nextbiomedical Co's current Enterprise Value is ₩299,682 Mil.
Nextbiomedical Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-959 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Nextbiomedical Co's EV-to-EBITDA for today is:

Nextbiomedical Co's current Enterprise Value is ₩299,682 Mil.
Nextbiomedical Co's EBITDA for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-710 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Nextbiomedical Co's EV-to-Revenue for today is:

Nextbiomedical Co's current Enterprise Value is ₩299,682 Mil.
Nextbiomedical Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩6,790 Mil.

4. EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow.

Nextbiomedical Co's EV-to-FCF for today is:

Nextbiomedical Co's current Enterprise Value is ₩299,682 Mil.
Nextbiomedical Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-631 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nextbiomedical Co Enterprise Value Related Terms

Thank you for viewing the detailed overview of Nextbiomedical Co's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Nextbiomedical Co Business Description